Could diet help slow symptoms of multiple sclerosis?

Weight Loss Meals
In our morning rounds, a new approach to fight multiple sclerosis — a disease where the body attacks its own central nervous system. MS affects about 400,000 people in the United States. It is two to three times more common among women. Current treatments may have severe side effects, and there is no cure. Dr. Tara Narula joins “CBS This Morning” to discuss a cutting edge, but low-tech attempt to slow the symptoms.

Subscribe to the “CBS This Morning” Channel HERE: http://bit.ly/1Q0v2hE
Watch “CBS This Morning” HERE: http://bit.ly/1T88yAR
Watch the latest installment of “Note to Self,” only on “CBS This Morning,” HERE: http://cbsn.ws/1Sh8XlB
Follow “CBS This Morning” on Instagram HERE: http://bit.ly/1Q7NGnY
Like “CBS This Morning” on Facebook HERE: http://on.fb.me/1LhtdvI
Follow “CBS This Morning” on Twitter HERE: http://bit.ly/1Xj5W3p
Follow “CBS This Morning” on Google+ HERE: http://bit.ly/1SIM4I8

Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T

Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8

Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B


Delivered by Charlie Rose, Norah O’Donnell and Gayle King, “CBS This Morning” offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for “CBS This Morning” broadcast times.

Products You May Like

Articles You May Like

These Dancers Want to Prove Breaking Isn’t a Joke After the Olympics Memes
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
I Tried Khloé Kardashian’s Glitter Compression Catsuit at a Solidcore Class
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage

Leave a Reply

Your email address will not be published. Required fields are marked *